Asymmetric synthesis of highly substituted beta-lactones by nucleophile-catalyzed [2+2] cycloadditions of disubstituted ketenes with aldehydes.Angew Chem Int Ed Engl. 2004 Nov 26; 43(46):6358-60.AC
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Language
eng
PubMed ID
15558690
Citation
Wilson, Jonathan E., and Gregory C. Fu. "Asymmetric Synthesis of Highly Substituted Beta-lactones By Nucleophile-catalyzed [2+2] Cycloadditions of Disubstituted Ketenes With Aldehydes." Angewandte Chemie (International Ed. in English), vol. 43, no. 46, 2004, pp. 6358-60.
Wilson JE, Fu GC. Asymmetric synthesis of highly substituted beta-lactones by nucleophile-catalyzed [2+2] cycloadditions of disubstituted ketenes with aldehydes. Angew Chem Int Ed Engl. 2004;43(46):6358-60.
Wilson, J. E., & Fu, G. C. (2004). Asymmetric synthesis of highly substituted beta-lactones by nucleophile-catalyzed [2+2] cycloadditions of disubstituted ketenes with aldehydes. Angewandte Chemie (International Ed. in English), 43(46), 6358-60.
Wilson JE, Fu GC. Asymmetric Synthesis of Highly Substituted Beta-lactones By Nucleophile-catalyzed [2+2] Cycloadditions of Disubstituted Ketenes With Aldehydes. Angew Chem Int Ed Engl. 2004 Nov 26;43(46):6358-60. PubMed PMID: 15558690.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Asymmetric synthesis of highly substituted beta-lactones by nucleophile-catalyzed [2+2] cycloadditions of disubstituted ketenes with aldehydes.
AU - Wilson,Jonathan E,
AU - Fu,Gregory C,
PY - 2004/11/24/pubmed
PY - 2005/9/24/medline
PY - 2004/11/24/entrez
SP - 6358
EP - 60
JF - Angewandte Chemie (International ed. in English)
JO - Angew Chem Int Ed Engl
VL - 43
IS - 46
SN - 1433-7851
UR - https://www.unboundmedicine.com/medline/citation/15558690/Asymmetric_synthesis_of_highly_substituted_beta_lactones_by_nucleophile_catalyzed_[2+2]_cycloadditions_of_disubstituted_ketenes_with_aldehydes_
DB - PRIME
DP - Unbound Medicine
ER -